AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F418-F426, 2009. First published November 19, 2008; doi:10.1152/ajprenal.90319.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
296/2/F418    most recent
90319.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vollenbröker, B.
Right arrow Articles by Weide, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vollenbröker, B.
Right arrow Articles by Weide, T.

mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes

Beate Vollenbröker,1,* Britta George,1,* Maria Wolfgart,1 Moin A. Saleem,2 Hermann Pavenstädt,1 and Thomas Weide1

1Universitätsklinikum Münster, Medizinische Klinik und Poliklinik D, Münster, Germany; and 2Academic and Children's Renal Unit, University of Bristol, Bristol, United Kingdom

Submitted 19 May 2008 ; accepted in final form 17 November 2008

The immunosuppressive mammalian target of rapamycin (mTOR) inhibitors can cause proteinuria, especially in kidney and heart transplanted patients. Podocytes play a major role in establishing the selective permeability of the blood-urine filtration barrier. Damage of these cells leads to proteinuria, a hallmark of most glomerular diseases. Interestingly, podocyte damage and focal segmental glomerulosclerosis can occur after treatment with an mTOR inhibitor in some transplant patients. To investigate the mechanisms of mTOR inhibitor-induced podocyte damage, we analyzed the effect of rapamycin on mTOR signaling and cellular function in human podocytes. We found that prolonged rapamycin treatment reduced the expression of total mTOR, which correlates with diminished levels of mTOR phosphorylation at Ser2448 and Ser2481. In addition, treatment with rapamycin reduced rictor expression and mTORC2 formation, resulting in a reduced phosphorylation of protein kinase B at Ser473. The expression level of the slit-diaphragm proteins nephrin and transient receptor potential cation channel 6 as well as the cytoskeletal adaptor protein Nck significantly decreased. Moreover, rapamycin reduced cell adhesion and cell motility, which was accompanied by an enhanced formation of dot-like actin-rich structures. Our data provide new molecular insights explaining which pathways and molecules are affected in podocytes by an imbalanced mTOR function because of rapamycin treatment.

sirolimus; proteinuria; slit diaphragm; mammalian target of rapamycin



Address for reprint requests and other correspondence: T. Weide, UKM, Medizinische Klinik und Poliklinik D, Abteilung: Molekulare Nephrologie, Domagkstr. 3a, D-48149 Münster, Germany (e-mail: weidet{at}uni-muenster.de)




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y. Sekine, Y. Nishibori, Y. Akimoto, A. Kudo, N. Ito, D. Fukuhara, R. Kurayama, E. Higashihara, E. Babu, Y. Kanai, et al.
Amino Acid Transporter LAT3 Is Required for Podocyte Development and Function
J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1586 - 1596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.